Texas, 36 States Reach $181 Million Settlement With Janssen Pharmaceuticals

Texas Attorney General Greg Abbott, along with attorneys general from 36 other states, announced a $181 million dollar settlement with Janssen Pharmaceuticals. The settlement follows a four-year investigation of unlawful and deceptive marketing of antipsychotic drugs.

The investigation revealed the Johnson & Johnson subsidiary urged physicians to prescribe Risperdal and other antipsychotic drugs for treatment of Alzheimer’s disease, dementia, depression, and anxiety. The U.S. Food and Drug Administration has approved Risperdal-related drugs only for the treatment of schizophrenia.

Tom Kelley is a spokesman for the Texas Attorney General’s Office.

“Physicians may or may not have decided to prescribe these drugs this way. That’s the physicians’ call. What a company may not do itself is to urge physicians to prescribe in an off-label manner — it’s called off-label marketing — and that’s exactly what was going on here.”

Texas will receive just over $11 million under the settlement. Earlier this year, the attorney general’s office resolved a similar case against Janssen involving Medicaid fraud. The latest agreement covers misrepresentations made to doctors of non-Medicaid patients.


Andrew Schneider

Andrew Schneider

Politics and Government Reporter

Andrew heads Houston Public Media’s coverage of national, state, and local elections. He also reports on major policy issues before the Texas Legislature and county and city governments across Greater Houston. Before taking up his current post, Andrew spent five years as Houston Public Media’s business reporter, covering the oil...

More Information